| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
821-50328103-801 18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:Devazepide;N-[(3S)-2,3-Dihydro-1-Methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxaMide
CAS:103420-77-5
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Products Intro: |
Product Name:Devazepide
CAS:103420-77-5
Purity:>=98% (HPLC) Package:5mg, 25mg Remarks:D3821
|
| Company Name: |
EMMX Biotechnology LLC
|
| Tel: |
888-539-0666 |
| Email: |
info@emmx.com |
| Products Intro: |
Product Name:Devazepide
CAS:103420-77-5
Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
|
| | DEVAZEPIDE Basic information |
| Product Name: | DEVAZEPIDE | | Synonyms: | N-[(3S)-2,3-DIHYDRO-1-METHYL-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPIN-3-YL]-1H-INDOLE-2-CARBOXAMIDE;DEVAZEPIDE;EVAZEPIDE, PANOS;(3S)-1-Methyl-3-[(1H-indol-2-yl)carbonylamino]-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one;L-364718;MK-329;(S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide;1H-Indole-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]- | | CAS: | 103420-77-5 | | MF: | C25H20N4O2 | | MW: | 408.45 | | EINECS: | | | Product Categories: | | | Mol File: | 103420-77-5.mol |  |
| | DEVAZEPIDE Chemical Properties |
| Boiling point | 758.6±60.0 °C(Predicted) | | density | 1.31±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: >5mg/mL | | pka | 13.25±0.40(Predicted) | | form | powder | | color | white to off-white |
| Hazard Codes | T+ | | Risk Statements | 28 | | Safety Statements | 28-36/37-45 | | RIDADR | UN 2811 6.1 / PGI | | WGK Germany | 3 | | RTECS | NL5994460 |
| | DEVAZEPIDE Usage And Synthesis |
| Uses | Antagonist (cholecystokinin). | | Uses | Devazepide has been used as a cholecystokinin receptor 1 (CCK1R) antagonist in human embryonic kidney 293T cells and in human pancreatic slices. | | Definition | ChEBI: An indolecarboxamide obtained by formal condensation of the carboxy group of indole-2-carboxylic acid with the exocyclic amino group of (3S)-3-amino-1-methyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one. A cholecystokinin antagonist used f
r treatment of gastrointestinal disorders. | | General Description | Devazepide is derived from asperlicin by chemical modification and has the benzodiazepine backbone. | | Biochem/physiol Actions | Devazepide is a CCK1 (CCK-A) receptor antagonist and a CCK8 antagonist. | | storage | Store at +4°C |
| | DEVAZEPIDE Preparation Products And Raw materials |
|